Literature DB >> 8574835

Recombinant vaccinia viruses expressing hepatitis A virus structural polypeptides: detection of an anti-VP0 response in convalescent-phase sera.

P Karayiannis1, S O'Rourke, R Watts, J Waters, V Hill, W F Carman, H C Thomas.   

Abstract

We have generated a number of recombinant vaccinia viruses which expressed the hepatitis A virus (HAV) structural polypeptides VP1, VP2, VP3, and VP4, either alone or in combination. The relevant sequences encoding these polypeptides were amplified from cloned cDNA by PCR and then cloned into the insertion vector pGS62. The presence of the HAV structural polypeptide-encoding sequences in the recombinant viruses was confirmed by Southern blot analysis, whilst their transcription and translation were demonstrated by Northern (RNA) blot analysis and immunodetection, respectively. Immunoprecipitation studies using these constructs have detected the presence of an anti-VP0 response in human convalescent sera following HAV infection. The significance of this finding and the usefulness of these constructs in studying cell-mediated immunity during recovery from HAV infection are discussed.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8574835      PMCID: PMC170226          DOI: 10.1128/cdli.2.6.708-711.1995

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  19 in total

1.  Detection of hepatitis A virus proteins in infected BS-C-1 cells.

Authors:  W S Updike; M Tesar; E Ehrenfeld
Journal:  Virology       Date:  1991-11       Impact factor: 3.616

2.  RNA-dependent cleavage of VP0 capsid protein in provirions of hepatitis A virus.

Authors:  N E Bishop; D A Anderson
Journal:  Virology       Date:  1993-12       Impact factor: 3.616

3.  Neutralizing monoclonal antibodies to hepatitis A virus: partial localization of a neutralizing antigenic site.

Authors:  J V Hughes; L W Stanton; J E Tomassini; W J Long; E M Scolnick
Journal:  J Virol       Date:  1984-11       Impact factor: 5.103

Review 4.  Picornaviral structure and assembly.

Authors:  J R Putnak; B A Phillips
Journal:  Microbiol Rev       Date:  1981-06

5.  General method for production and selection of infectious vaccinia virus recombinants expressing foreign genes.

Authors:  M Mackett; G L Smith; B Moss
Journal:  J Virol       Date:  1984-03       Impact factor: 5.103

6.  Vaccinia virus thymidine kinase and neighboring genes: mRNAs and polypeptides of wild-type virus and putative nonsense mutants.

Authors:  G Bajszár; R Wittek; J P Weir; B Moss
Journal:  J Virol       Date:  1983-01       Impact factor: 5.103

7.  Immunologic priming with recombinant hepatitis A virus capsid proteins produced in Escherichia coli.

Authors:  T F Powdrill; J M Johnston
Journal:  J Virol       Date:  1991-05       Impact factor: 5.103

8.  Analysis of a potential myristoylation site in hepatitis A virus capsid protein VP4.

Authors:  M Tesar; X Y Jia; D F Summers; E Ehrenfeld
Journal:  Virology       Date:  1993-06       Impact factor: 3.616

9.  Synthesis and assembly of hepatitis A virus-specific proteins in BS-C-1 cells.

Authors:  S V Borovec; D A Anderson
Journal:  J Virol       Date:  1993-06       Impact factor: 5.103

10.  Antigenic structure of human hepatitis A virus defined by analysis of escape mutants selected against murine monoclonal antibodies.

Authors:  L H Ping; S M Lemon
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.